运动医学市场－全球产业规模、份额、趋势、机会、预测：按产品、应用、地区和竞争对手划分，2021-2031年

全球运动医学市场预计将从 2025 年的 73.4 亿美元成长到 2031 年的 104.2 亿美元，复合年增长率为 6.01%。

此领域涵盖专门的医疗设备、重组产品和辅助系统，旨在预防、诊断和治疗运动伤害。推动这一领域成长的主要因素是全球日益增长的积极生活方式，这与需要临床治疗的肌肉骨骼创伤发生率的上升密切相关。例如，根据美国国家安全委员会的数据，预计到2024年，因运动和运动器材造成的损伤将达到564,845例，这意味着需要医疗干预的病例数量庞大，并推动了对整形外科解决方案和復健辅助器具的需求。

然而，关节镜手术和整形外科植入的高成本构成了市场准入的重大障碍。这些高昂的价格，加上各地不同的报销政策，限制了病患获得必要治疗的机会，并阻碍了价格敏感市场对先进技术的应用。因此，这些经济限制仍然是扩大市场渗透率和限制高品质医疗干预措施广泛普及的重要障碍。

市场驱动因素

微创外科技术的创新正在改变全球运动医学市场，提高手术精确度并缩短患者復原时间。高清视觉化系统和机器人辅助技术在关节镜手术中的应用，使外科医生能够以最小的组织损伤治疗复杂的肌肉骨骼损伤，从而为这些专用器械的製造商带来可观的收入。史密斯医疗（Smith & Nephew）于2024年10月发布的2024年第三季财报清晰地印证了这一趋势。报告指出，受视讯和切除平台强劲需求的推动，关节镜手术辅助技术部门的收入成长了15.0%，凸显了该产业对先进设备在改善临床疗效方面的高度依赖。

同时，全球体育健身活动的兴起是市场成长的主要驱动力。这是因为随着运动量的增加，运动伤害的发生率也在上升。这种上升趋势在青少年和高中体育运动中尤其显着，参与人数的增加扩大了需要预防和復健性整形外科护理的患者群体。根据美国高中体育协会联合会（NFHS）于2024年8月发布的《2023-2024学年高中体育运动参与调查》，高中体育参与人数超过800万，创历史新高。如此活跃的人群支撑着主要企业的强劲业绩；例如，史赛克公司报告称，其医疗外科和神经技术部门在2024年第三季度的净销售额增长了12.8%。

市场挑战

关节镜手术和整形外科植入的高昂费用是全球运动医学市场扩张的主要障碍。先进的重组产品和专用医疗设备往往价格昂贵，在发展中地区和预算紧张的医疗体系中难以取得。当医疗机构面临资金限制时，它们被迫推迟引进这些关键技术或选择更便宜的替代方案，造成经济摩擦。这降低了製造商的销售量，使其难以打入大众市场，进而减缓了整体市场成长速度。

医疗报销政策的不稳定性及其不断下降加剧了这项挑战，给医疗机构的营运预算带来了沉重负担。由于保险支付未能跟上通货膨胀和营运成本上涨的步伐，医疗机构在资本投资方面变得更加谨慎。据美国整形外科学会称，到2024年，联邦医疗保险（Medicare）的医生报销比例将下降约3.37%，这将给骨科医生带来额外的经济负担。报销能力的下降迫使医疗专业人员减少对高端运动医学解决方案的投资，从而直接阻碍了新兴工业技术的应用。

市场趋势

随着医疗服务提供者寻求更有效率、更经济的运动医学介入模式，整形外科手术向门诊手术中心（ASC）的转变正在从根本上改变市场结构。这项转变的驱动力在于麻醉技术和微创技术的进步，这些进步使得即使是韧带重组等复杂手术也能在门诊安全进行。因此，製造商正专注于小型化设备和精简的库存管理系统，并调整产品线以满足这些中心的特定需求。财务数据也印证了这项结构性变化。例如，泰尼特医疗（Tenet Healthcare）于2024年10月发布的2024年第三季财报显示，其门诊服务部门的净营业收入年增21.0%，显示该公司对这些机构的依赖程度日益加深。

同时，再生医学和骨生物製药的引入正在改变临床策略，将重点从单纯的机械固定转向生物修復。临床医生正积极采用富血小板血浆（PRP）、骨移植替代物和透明质酸等治疗方法来促进组织修復，并满足患者对恢復自然生理功能的治疗方法需求，从而延缓侵入性关节重建手术的必要性。这些生物解决方案的市场潜力在公司业绩中得到了充分体现。在2024年11月发布的2024年第三季财报中，Bioventus公司报告称，其全球收入同比增长15.0%，这主要得益于疼痛管理和外科解决方案的两位数增长，凸显了市场对主动修復技术的日益青睐。

目录

第一章概述

第二章：调查方法

第三章执行摘要

第四章：客户心声

第五章：全球运动医学市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 产品类别（身体重组与修復（外科器械、软组织修復、骨骼重组器械）、身体支撑与復健（矫正器具及其他支撑器材、压力衣、冷热疗法）、身体监测与评估（心臟、呼吸、血液动力学、肌肉骨骼、其他）、配件（绷带、胶带、消毒剂、包扎带、其他））
  • 按下应用部位（膝盖、肩膀、脚踝/脚部、背部/脊椎、手肘/腕部、髋部、其他）
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章：北美运动医学市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国别分析
  • 我们
  • 加拿大
  • 墨西哥

第七章：欧洲运动医学市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国别分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区运动医学市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国别分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲运动医学市场展望

• 市场规模及预测
• 市占率及预测
• 中东与非洲：国别分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美运动医学市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国别分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 促进因素
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 近期趋势

第十三章：全球运动医学市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的潜力
• 供应商的议价能力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Teva Pharmaceutical Industries Ltd.
• Karl Storz SE & Co. KG
• CONMED Corporation
• Smith & Nephew plc
• Stryker Corporation
• Breg Inc.
• DJO Global, Inc.
• Mueller Sports, Inc.
• Wright Medical Group NV
• Medtronic plc.
• Performance Health International Limited

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Sports Medicine Market is projected to expand from USD 7.34 Billion in 2025 to USD 10.42 Billion by 2031, registering a CAGR of 6.01%. This sector comprises specialized medical devices, body reconstruction products, and support systems aimed at preventing, diagnosing, and treating injuries resulting from physical activities. A key catalyst for this growth is the worldwide increase in active lifestyles, which correlates with a higher frequency of musculoskeletal trauma requiring clinical care. For example, data from the National Safety Council indicates that exercise and exercise equipment were responsible for an estimated 564,845 injuries in 2024, underscoring the significant volume of cases needing medical attention and fueling demand for orthopedic solutions and rehabilitation aids.

However, the market faces a substantial hurdle due to the high costs associated with arthroscopic procedures and orthopedic implants. These elevated prices, compounded by inconsistent reimbursement policies across various regions, restrict patient access to essential treatments and hinder the adoption of advanced technologies in price-sensitive markets. Consequently, these financial constraints remain a significant barrier preventing broader market penetration and limiting the widespread availability of premium medical interventions.

Market Driver

Technological innovations in minimally invasive surgical techniques are transforming the Global Sports Medicine Market by improving surgical accuracy and shortening patient recovery periods. The incorporation of high-definition visualization systems and robotic assistance into arthroscopic procedures enables surgeons to address complex musculoskeletal injuries with minimal tissue damage, driving significant revenue for manufacturers of these specialized tools. This trend is exemplified by Smith+Nephew's 'Third Quarter 2024 Trading Report' from October 2024, which noted a 15.0% revenue increase in their Arthroscopic Enabling Technologies segment, attributed to robust demand for their video and resection platforms, highlighting the industry's dependence on advanced equipment to enhance clinical outcomes.

Simultaneously, the rising global engagement in sports and physical fitness serves as a major driver for market growth, as increased activity levels lead to a higher incidence of sports-related injuries. This upward trend is especially notable in organized youth and high school athletics, where growing participation rates generate a larger patient pool needing preventive and restorative orthopedic care. According to the National Federation of State High School Associations' August 2024 '2023-24 High School Athletics Participation Survey', high school sports participation hit a record high of over 8 million. This active demographic supports strong financial results for major corporations; for instance, Stryker reported a 12.8% increase in net sales for its MedSurg and Neurotechnology segment in the third quarter of 2024.

Market Challenge

The substantial expense linked to arthroscopic procedures and orthopedic implants represents a major impediment to the expansion of the global sports medicine market. Advanced reconstruction products and specialized medical devices frequently come with premium price tags, limiting their attainability in developing regions and healthcare systems with strict budget constraints. When medical facilities face financial limitations, they are often compelled to postpone acquiring these essential technologies or select less costly alternatives, creating economic friction that reduces sales volumes for manufacturers and decelerates the overall rate of market growth by making mass market penetration financially difficult.

This challenge is further exacerbated by inconsistent and decreasing reimbursement policies, which place significant strain on the operational budgets of medical practices. As insurance payments struggle to match inflation and rising operational costs, healthcare providers are becoming more cautious regarding capital expenditures. According to the American Academy of Orthopaedic Surgeons, the Medicare Physician Fee Schedule conversion factor was cut by approximately 3.37 percent in 2024, imposing extra financial stress on orthopedic surgeons. This decline in reimbursement power compels practitioners to curtail investment in high-end sports medicine solutions, posing a direct barrier to the widespread adoption of emerging industry technologies.

Market Trends

The migration of orthopedic procedures toward Ambulatory Surgery Centers is fundamentally reshaping the market as providers search for more efficient and cost-effective delivery models for sports medicine interventions. This transition is driven by improvements in anesthesia and minimally invasive technologies, allowing complex surgeries like ligament reconstructions to be safely conducted in outpatient environments. Consequently, manufacturers are adapting their product lines to meet the specific needs of these centers by focusing on compact equipment and streamlined inventory systems. Financial data confirms this structural shift; for example, Tenet Healthcare's 'Third Quarter 2024 Earnings Release' in October 2024 reported a 21.0% year-over-year increase in net operating revenues for their Ambulatory Care segment, underscoring the growing reliance on these facilities.

Concurrently, the incorporation of regenerative medicine and orthobiologics is transforming clinical strategies by emphasizing biological healing over purely mechanical fixation. Clinicians are increasingly adopting therapies such as platelet-rich plasma, bone graft substitutes, and hyaluronic acid to expedite tissue repair and postpone the necessity for invasive joint replacements, addressing the need for treatments that restore natural physiology. The market potential of these biological solutions is evident in corporate performance; Bioventus reported in its 'Third Quarter 2024 Financial Results' in November 2024 that worldwide revenue rose by 15.0% year-over-year, led by double-digit growth in pain treatments and surgical solutions, highlighting the increasing preference for active healing technologies.

Key Market Players

• Teva Pharmaceutical Industries Ltd.
• Karl Storz SE & Co. KG
• CONMED Corporation
• Smith & Nephew plc
• Stryker Corporation
• Breg Inc.
• DJO Global, Inc.
• Mueller Sports, Inc.
• Wright Medical Group N.V.
• Medtronic plc.
• Performance Health International Limited

Report Scope

In this report, the Global Sports Medicine Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Sports Medicine Market, By Product

• Body Reconstruction & Repair (Surgical Equipment, Soft Tissue Repair, Bone Reconstruction Devices)
• Body Support & Recovery (Braces and Other Support Devices, Compression Clothing, Hot & Cold Therapy)
• Body Monitoring & Evaluation (Cardiac, Respiratory, Hemodynamic, Musculoskeletal, Others)
• Accessories (Bandages, Tapes, Disinfectants, Wraps, Other)

Sports Medicine Market, By Application

• Knees
• Shoulders
• Ankle & Foot
• Back & Spine
• Elbow & Wrist
• Hips
• Others

Sports Medicine Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Sports Medicine Market.

Available Customizations:

Global Sports Medicine Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Sports Medicine Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Body Reconstruction & Repair (Surgical Equipment, Soft Tissue Repair, Bone Reconstruction Devices), Body Support & Recovery(Braces and Other Support Devices, Compression Clothing, Hot & Cold Therapy), Body Monitoring & Evaluation(Cardiac, Respiratory, Hemodynamic, Musculoskeletal, Others), Accessories( Bandages, Tapes, Disinfectants, Wraps, Other))
  • 5.2.2. By Application (Knees, Shoulders, Ankle & Foot, Back & Spine, Elbow & Wrist, Hips, Others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2025)
• 5.3. Market Map

6. North America Sports Medicine Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Application
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Sports Medicine Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Application
  • 6.3.2. Canada Sports Medicine Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Application
  • 6.3.3. Mexico Sports Medicine Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Application

7. Europe Sports Medicine Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Application
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Sports Medicine Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Application
  • 7.3.2. France Sports Medicine Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Application
  • 7.3.3. United Kingdom Sports Medicine Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Application
  • 7.3.4. Italy Sports Medicine Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Application
  • 7.3.5. Spain Sports Medicine Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Application

8. Asia Pacific Sports Medicine Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Application
  • 8.2.3. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Sports Medicine Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Application
  • 8.3.2. India Sports Medicine Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Application
  • 8.3.3. Japan Sports Medicine Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Application
  • 8.3.4. South Korea Sports Medicine Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Application
  • 8.3.5. Australia Sports Medicine Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Application

9. Middle East & Africa Sports Medicine Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Application
  • 9.2.3. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Sports Medicine Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Application
  • 9.3.2. UAE Sports Medicine Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Application
  • 9.3.3. South Africa Sports Medicine Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Application

10. South America Sports Medicine Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Application
  • 10.2.3. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Sports Medicine Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Application
  • 10.3.2. Colombia Sports Medicine Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Application
  • 10.3.3. Argentina Sports Medicine Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Application

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Sports Medicine Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Teva Pharmaceutical Industries Ltd.
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Karl Storz SE & Co. KG
• 15.3. CONMED Corporation
• 15.4. Smith & Nephew plc
• 15.5. Stryker Corporation
• 15.6. Breg Inc.
• 15.7. DJO Global, Inc.
• 15.8. Mueller Sports, Inc.
• 15.9. Wright Medical Group N.V.
• 15.10. Medtronic plc.
• 15.11. Performance Health International Limited

16. Strategic Recommendations

17. About Us & Disclaimer